B. Braun Group is a leading medical technology company with a strong focus on protecting and improving global health. With a workforce of over 65,000 employees, the family-owned company is committed to developing innovative solutions and setting high standards in healthcare. In 2022, the B. Braun Group achieved an impressive €8.5 billion in sales, showcasing its significant market impact.
The company fosters a collaborative work environment that encourages open-mindedness, continuous learning, and collective problem-solving. Embracing the rapid pace of technological change, B. Braun Group emphasizes the importance of constantly enhancing the solutions it provides. Furthermore, the company promotes innovative thinking and a culture of accountability, reflecting its commitment to excellence in the medical technology sector.
B. Braun Group's diverse set of industries includes Education, Health Care, Manufacturing, Medical Devices, and Pharmaceutical, demonstrating its wide-ranging impact across various sectors.
The last investment of $25.00K in Debt Financing was secured on 27 October 2020, with Ben Franklin Technology Partners of Northeastern Pennsylvania being the investing party, indicating the company's ability to attract strategic investments. As the company continues to expand its global reach and influence, it presents an appealing opportunity for potential investors seeking to contribute to the advancement of healthcare on a significant scale.
For more information, please refer to the company's Imprint here and Privacy Policy here.
No recent news or press coverage available for B. Braun Group.